French Polynesia Introduces Stricter Regulations on E-Cigarettes in 2025

Jul.25.2024
French Polynesia Introduces Stricter Regulations on E-Cigarettes in 2025
French Polynesia to ban disposable e-cigarettes in 2025, following mainland France's ban in 2024, aiming to reduce addiction risks.

According to the French media TVTN, on July 24, 2024, French Polynesia will ban disposable e-cigarettes in 2025, following the ban that took place in mainland France in September 2024.


This Wednesday (July 24th), the local health department recommended updating tobacco product regulatory laws, including e-cigarette devices, with the aim of "making these products more difficult to access and reducing the risk of addiction, especially among young people.


The government department hopes to address new challenges and strengthen tobacco control efforts in French Polynesia by revising regulations.


The revised regulations primarily include the following aspects:


Ban on the sale of disposable e-cigarette devices, restrictions on permissible flavors.


Use plain packaging to reduce visual appeal.


Restricting the nicotine content, tank size, and refillable e-liquid capacity of e-cigarettes to reduce their usage risk.


Reexamine tobacco product taxes.


A license is required in order to import, manufacture, and sell these products.


Resist tobacco product manufacturers' marketing strategies and restrict promotional efforts surrounding these products.


Designating specific areas for its consumption.


The department is currently consulting with experts in the economic and medical industries, and this consultation will continue until the end of August. This new law is scheduled to take effect in early 2025.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
Russia’s Environmental Operator Proposes Raising Eco Levies on E-Cigarette Manufacturers: “Fee-Driven Remediation” for Hazardous Waste
Russia’s Environmental Operator Proposes Raising Eco Levies on E-Cigarette Manufacturers: “Fee-Driven Remediation” for Hazardous Waste
Because disposable e-cigarettes (with onboard batteries) are difficult to recycle, costly to process, and pose environmental risks, the Russian Environmental Operator (REO) has proposed increasing the environmental (eco) levy on manufacturers and importers of e-cigarettes. REO says the proceeds would fund compliant disposal firms and push improvements in product design and take-back capacity. The funds collected would be directed to support licensed processors, and REO is currently working with
Sep.25 by 2FIRSTS.ai
InterTabac 2025 Insights|Altria Brings Two Nicotine Pouch Brands—On! and FUMi to InterTabac
InterTabac 2025 Insights|Altria Brings Two Nicotine Pouch Brands—On! and FUMi to InterTabac
2Firsts’ on-site reporting at InterTabac 2025 in Dortmund, Germany, found that Altria exhibited two nicotine pouch brands: On! and FUMi.
Sep.19 by 2FIRSTS.ai
2Firsts Insights | From Limited-Edition Frenzy to Interactive Lead-Gen: The 2025 Halloween Shift in Vape Marketing
2Firsts Insights | From Limited-Edition Frenzy to Interactive Lead-Gen: The 2025 Halloween Shift in Vape Marketing
For Halloween 2025, leading vape brands such as HQD and ELFBAR are running overseas social-media engagement campaigns—covering points programs and UGC giveaways with age/region restrictions. Unlike 2024’s wave of themed devices, no brand-new Halloween limited editions have appeared on major U.S. channels this year; only RAZ has restocked last year’s version.
Oct.31 by 2FIRSTS.ai
Thai police seize over 50,000 illegal e-cigarettes worth more than 10 million baht, main suspect arrested in Bangkok
Thai police seize over 50,000 illegal e-cigarettes worth more than 10 million baht, main suspect arrested in Bangkok
Thai police cracked an illegal e-cigarette smuggling case, seized 50,000 items worth more than 10 million baht (over 310,000 US dollars), arrested several suspects, and cracked down on a cross-border smuggling network.
Sep.23 by 2FIRSTS.ai
Sven Löhr Appointed as New Managing Director of British American Tobacco Austria GmbH, Plans to Lead Company's Smoke-Free Strategy to Reduce Smoking Rates in Austria to 5% by 2040
Sven Löhr Appointed as New Managing Director of British American Tobacco Austria GmbH, Plans to Lead Company's Smoke-Free Strategy to Reduce Smoking Rates in Austria to 5% by 2040
Sven Löhr appointed as new Managing Director of British American Tobacco Austria, focusing on smoke-free future and market leadership.
Sep.03 by 2FIRSTS.ai